PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Apr-2024 Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 Epigenomics AG
30-Apr-2024 SYNLAB Italy has restored operations after cyber-attack SYNLAB AG
30-Apr-2024 Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines Benchling
30-Apr-2024 Bayer and Evotec collaborate to advance precision cardiology Evotec SE
30-Apr-2024 Relief Therapeutics has published its Annual Report Relief Therapeutics Holding SA
30-Apr-2024 Final allocation of DocMorris CHF 200 million Convertible Bonds Offering DocMorris AG
30-Apr-2024 Newron announces positive top-line results from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients Newron Pharmaceuticals S.p.A.
30-Apr-2024 Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report Xlife Sciences AG
30-Apr-2024 Straumann Group showed a solid start into 2024, with varied regional growth dynamic Straumann Holding AG
29-Apr-2024 MorphoSys AG Reports First Quarter 2024 Financial Results MorphoSys AG
29-Apr-2024 Biophytis is deploying its partnership strategy in obesity Biophytis
29-Apr-2024 Gerresheimer partners with RxCap to offer connected adherence solutions Gerresheimer AG
29-Apr-2024 Jefferies Reiterates “Buy” Rating on Modern Dental (03600.HK) with HK$8.50 Target Price   Modern Dental Group Limited
29-Apr-2024 selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis selectION, Inc.
26-Apr-2024 RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting Relief Therapeutics Holding SA
26-Apr-2024 Stockholm, Sweden – April 26 2024 – OncoZenge AB (publ), a leading pharmaceutical company developing BupiZenge™, an innovative, non-opioid treatment for oral pain, today announces the appointment of Anna Asplind as Phase 3 Program Manager. OncoZenge
26-Apr-2024 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda HUTCHMED
26-Apr-2024 Innovation in generics: Increased efficiency through peptide API synthesis expertise Bachem
26-Apr-2024 CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth Cheplapharm AG
26-Apr-2024 M1 Kliniken AG decides to start share buyback M1 Kliniken AG